Key Principles and Recommended Regimens for First-line Antiretroviral Therapy

  • Author: Paul E. Sax, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 2/20/19 (What's New)

Considerations for Choosing a First-line NNRTI

When choosing among efavirenz, doravirine, and rilpivirine, the latter would be a reasonable option in patients with baseline HIV-1 RNA < 100,000 copies/mL and CD4+ cell count > 200 cells/mm³, where the better tolerability of rilpivirine is not offset by excess risk of virologic failure. Additional considerations for the use of rilpivirine...

Action required

Keywords: Adherence, Biomedical Prevention, Dyslipidemia, Initial Antiretroviral Therapy, Management of Treatment-Experienced Patients, Pregnancy, Psychiatric Disorders, Treatment Complications, Women

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.